利伐沙班的用法用量

(Rivaroxaban) is a typical direct blocker of factor

In clinical applications, rivaroxaban (Xarelto) has the advantages of high safety factor, high bioavailability, no cross-resistance, high compliance, and no need to monitor INR. With further clinical promotion and application, this drug has gradually been considered as the drug of choice for the prevention and treatment of deep venous thrombosis of lower limbs. Mastering the correct usage and dosage of rivaroxaban has become an important issue faced by patients.

So, how should patients in the indication group use this drug when treated with rivaroxaban?

Since the dosage forms and specifications of rivaroxaban on the market are different, there will be certain differences in its specific usage and dosage. Under normal circumstances, the recommended dose of rivaroxaban is 10 mg/time, once/day, and the medication is taken orally. When the wound has stopped bleeding, the patient's first medication should be administered between 6 and 10 hours after surgery.

The duration of treatment depends on the patient's risk of venous thromboembolic events. For patients who undergo major hip surgery, the clinically recommended treatment course is 5 weeks; for patients who undergo major knee surgery, the clinically recommended course of treatment is 2 weeks. After patients purchase the medicine and use it, they need to keep it sealed at room temperature (10-30°C) and put it out of the reach of children to prevent drug failure and accidental ingestion by children.

Recommended hot articles: /newsDetail/73094.html